Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051110A1 Corrective clothes with crotch
06/09/2005WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124683 Viricides; immunomoderators
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124662 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
06/09/2005US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/09/2005US20050124655 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors
06/09/2005US20050124652 Guanidino compounds
06/09/2005US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta
06/09/2005US20050124638 Benzimidazoles and analogs thereof as antivirals
06/09/2005US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease
06/09/2005US20050124630 Bicyclic indolyl derivatives and methods for their use as serotonergic agents
06/09/2005US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
06/09/2005US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders
06/09/2005US20050124624 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
06/09/2005US20050124620 Indole derivatives having an acidic moiety that inhibit or modulate activity of p38 map kinase mediating a disease state; e.g., 3-(2-(4-pyridyl)ethyl)-5-(3-trifluoromethoxybenzamido)indole; enzyme inhibitors; antiarthritic, -inflammatory, and -carcinogenic agents; respiratory disorders; AIDS; Alzheimer's
06/09/2005US20050124619 Medical devices employing triazine compounds and compositions thereof
06/09/2005US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy
06/09/2005US20050124611 Such as N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]-4-morpholineacetamide; potassium channel modulators
06/09/2005US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
06/09/2005US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism
06/09/2005US20050124600 And thiones, 1-substituted with a (hetero)aryl)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops
06/09/2005US20050124599 Novel benzoimidazole derivatives useful as antiproliferative agents
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050124497 Pesticide, 5-tert-butyl-2-{4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]phenyl}-1,3-benzoxazole; chemical intermediates, N-(5-tert-butyl-2-hydroxyphenyl)-4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]benzamide; applying on plants, animals
06/09/2005US20050124209 Illuminated electrical cords and outlets
06/09/2005DE10352499A1 Substituierte Dihydrochinazoline II Substituted dihydroquinazolines II
06/09/2005CA2547472A1 Cyclic amine derivative having heteroaryl ring
06/09/2005CA2546932A1 Quinazolinone compounds as anticancer agents
06/09/2005CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005CA2546673A1 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
06/09/2005CA2546493A1 Indazole compounds and methods of use thereof as protein kinase inhibitors
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546360A1 Methods of treating diseases and disorders by targeting multiple kinases
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546264A1 4-phenylpiperidine derivatives as renin inhibitors
06/09/2005CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005CA2545262A1 Quinazoline derivatives
06/09/2005CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/08/2005EP1538159A1 Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1538145A1 Process for production of phenoxy-substituted 2-pyridone compounds
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537111A1 Hetereoaryl nitrile derivatives
06/08/2005EP1537102A1 Inhibition of phsphoinostide 3-dinase beta
06/08/2005EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
06/08/2005EP1537099A1 Pyrrole based inhibitors of glycogen synthase kinase 3
06/08/2005EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537097A2 Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
06/08/2005EP1537089A2 Compounds compositions and methods
06/08/2005EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537085A1 Oxytocin inhibitors
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537081A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
06/08/2005EP1537078A1 Indoles having anti-diabetic activity
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1536799A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536796A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
06/08/2005EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1536684A2 Method for the prevention and/or treatment of atherosclerosis
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1370528B1 Mch antagonists and their use in the treatment of obesity
06/08/2005EP1337526B1 Substituted imidazoles useful in the treatment of inflammatory diseases
06/08/2005EP1294710B1 Indole derivatives useful for the treatment of cns disorders
06/08/2005EP1263301A4 Method and system for assay and removal of harmful toxins during processing of tobacco products
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP1019045B1 Antithrombotic agents
06/08/2005CN1625555A Quinazoline compounds
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals
06/08/2005CN1205202C N-carbanilides used as pesticides
06/08/2005CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
06/07/2005US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions
06/07/2005US6903217 Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
06/07/2005US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903213 HIV inhibiting pyrimidine derivatives
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903126 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/07/2005US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 1080